Filing Details
- Accession Number:
- 0000899243-20-035005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-23 17:22:56
- Reporting Period:
- 2020-12-22
- Accepted Time:
- 2020-12-23 17:22:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1627766 | E Sean George | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-12-22 | 236 | $51.62 | 634,457 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-12-22 | 2,739 | $52.95 | 631,718 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-12-22 | 700 | $53.99 | 631,018 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales of common stock were effected pursuant to a Rule 10b-5 sales plan adopted by the reporting person on August 12, 2020.
- Represents a weighted average sale price. Actual sale prices ranged from $51.17 to $52.03 per share.
- The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- Represents a weighted average sale price. Actual sale prices ranged from $52.58 to $53.32 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $53.73 to $54.30 per share.
- Includes an aggregate of 226,598 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.